Evidence map›Paper›PMID 41655992›Full record

ArticleTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy2026

Intraoperative Collection of Ascitic Fluid With Intra- or Postoperative Reinfusion in Ovarian Cancer: Safety and Feasibility of a Roller Pumping Method.

Yutaka Yoneoka, Tsukuru Amano, Akimasa Takahashi, Mari Deguchi, Hiroyuki Yamanaka, Yuji Tanaka, Shunichiro Tsuji, Takashi Murakami

Abstract read
In one paragraph

Article in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yutaka YoneokaDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.ORCID https://orcid.org/0000-0002-8255-6293
Tsukuru AmanoDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.ORCID https://orcid.org/0000-0003-2919-6337
Akimasa TakahashiDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Mari DeguchiDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Hiroyuki YamanakaDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Yuji TanakaDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.ORCID https://orcid.org/0000-0002-7045-8151
Shunichiro TsujiDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Takashi MurakamiDepartment of Obstetrics and Gynecology, Shiga University of Medical Science, Otsu, Shiga, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with ovarian cancer often present with massive ascites, leading to significant protein loss during surgical procedures. Although cell-free concentrated ascites reinfusion therapy (CART) is used in palliative settings to mitigate protein loss, its application in intraoperative settings remains unexplored.

methodsWe retrospectively evaluated patients who underwent intraoperative CART for ovarian cancer treatment between March 2022 and 2025, compared two ascitic fluid collection methods (syringe and roller pumping), and analyzed operative parameter, fluid collection efficiency, albumin recovery, and adverse event-related data.

resultsAmong the 12 patients included in this study, seven (58.3%) underwent CART using the roller pumping method, which significantly reduced the collection time compared with the syringe method (9 vs. 22 min, p < 0.05). The median collection speed was also significantly higher with the roller pumping method (404 vs. 140 mL/min, p < 0.05). Approximately 70% of the albumin in the collected ascitic fluid was successfully reinfused. Adverse events included transient hypotension (16.7%) and hypertension (25.0%), both of which resolved without intervention.

conclusionIntraoperative CART is a feasible and safe technique for protein loss management in patients undergoing surgery for ovarian cancer. The roller pumping method significantly shortened ascites collection time and reduced surgical burden.

Indexed as

AscitesAscitic FluidIntraoperative CareOvarian NeoplasmsAgedFeasibility StudiesFemaleHumansMiddle AgedRetrospective StudiesalbuminsascitesCARTovarian neoplasms

Identifiers

PMID41655992
PMCPMC13124457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.